retatrutide chemyo RCSB PDB Retatrutide (LY3437943) | GCGR/GLP-1R Inhibitor

It's early

Lamictal XR is a safe and effective treatment when used for FDA licensed indications

This is often due to the loss of facial fat pads

Originally designed as a treatment for type II diabetes, in 2021, the FDA approved Semaglutide to be used as a weight loss treatment

Oral GLP-1 pill delivers nearly 12 percent weight loss in 36 weeks, study finds (NewsNation) Patients taking the oral GLP-1 drug aleniglipron saw up to a 12 percent reduction in body weight after 36 weeks, according to researchers

A compound that simultaneously activates three distinct receptor types, in Retatrutides case the GLP-1, GIP, and glucagon receptors